Concepedia

R. S. K. Vijayan

RS

Statistics

Publications

4

Citations

814

H-Index

4

Active since

2019

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Foundation Medicine (United States)

Guardant (United States)

R. S. K. Vijayan is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2019–2024

4

Publications

4

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Jacqulyne Robichaux, Xiuning Le, R. S. K. Vijayan et al. · Nature · 2021 · 452 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Jacqulyne Robichaux, Yasir Y. Elamin, R. S. K. Vijayan et al. · Cancer Cell · 2019 · 241 citations · Full text

Medicine, Oncology, Pharmacology +14

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Yasir Y. Elamin, Jacqulyne Robichaux, Brett W. Carter et al. · Cancer Cell · 2022 · 106 citations · Full text

Medicine, Oncology, Pharmacology +14

Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers

Christopher L. Carroll, Michael G. Johnson, Yanbing Ding et al. · Journal of Medicinal Chemistry · 2024 · 15 citations

Medicine, Oncology, Pharmacology +14

1–4 of 4